The HPV Vaccine: Moving Beyond Teenage Populations

The human papillomavirus (HPV) vaccination, first introduced in the U.S. more than 10 years ago was designed to protect young women from cervical cancer. Since that time, the Centers for Disease Control & Prevention (CDC) reports that HPV cancers and genital warts have decreased by 71% among teen girls. The vaccine’s success has led to research identifying new opportunities for protection against HPV among other patient populations that can help further drive down infection rates.

Sign up to the
MASSAFP Email List